The Technical Analyst
Select Language :
Lexaria Bioscience Corp. [LEXX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Lexaria Bioscience Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Lexaria Bioscience Corp. is listed at the  Exchange

-2.16% $3.63

America/New_York / 28 mar 2024 @ 16:00


Lexaria Bioscience Corp.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 44.93 mill
EPS: -0.840
P/E: -4.32
Earnings Date: Apr 12, 2024
SharesOutstanding: 12.38 mill
Avg Daily Volume: 0.480 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Neutral
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -4.32 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.73x
Company: PE -4.32 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-1.563
(-143.06%) $-5.19
Date: 2024-03-29
Expected Trading Range (DAY)

$ 3.09 - 4.19

( +/- 15.00%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Cabatuan Nelson Sell 200 000 Stock Options
2023-10-26 Carle Vanessa Buy 12 500 Stock Options
2023-10-26 Docherty John Martin Buy 30 000 Stock Options
2023-10-26 Bunka Christopher Buy 30 000 Stock Options
2023-07-25 Baxter Nicholas W Buy 5 000 Stock Options
INSIDER POWER
-22.08
Last 99 transactions
Buy: 4 974 810 | Sell: 2 651 735

Forecast: 16:00 - $3.64

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.64
Forecast 2: 16:00 - $3.64
Forecast 3: 16:00 - $3.64
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.63 (-2.16% )
Volume 0.168 mill
Avg. Vol. 0.480 mill
% of Avg. Vol 35.04 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Lexaria Bioscience Corp.

Last 12 Months

Last 12 months chart data with high, low, open and close for Lexaria Bioscience Corp.

RSI

Intraday RSI14 chart for Lexaria Bioscience Corp.

Last 10 Buy & Sell Signals For LEXX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Last 10 Buy Signals

Date Signal @
DASHUSDMar 29 - 08:57$39.61
NEXOUSDMar 29 - 08:531.331
BCHUSDMar 29 - 08:54$623.70
ROUTEUSDMar 29 - 08:504.37
OSMOUSDMar 29 - 08:451.380
BELUSDMar 29 - 08:440.982
DPIUSDMar 29 - 08:44$145.76
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55
MPLUSDMar 29 - 08:3422.12

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.